Back to Journals » Hepatic Medicine: Evidence and Research » Volume 2

Anti-inflammatory action of insulin via induction of Gadd45-β transcription by the mTOR signaling pathway

Authors Bortoff KD, Keeton AB, Franklin JL, Messina J

Published 24 June 2010 Volume 2010:2 Pages 79—85

DOI https://doi.org/10.2147/HMER.S7083

Review by Single-blind

Peer reviewer comments 3


Katherine D Bortoff1, Adam B Keeton1, J Lee Franklin1, Joseph L Messina1,2

1Department of Pathology, Division of Molecular and Cellular Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, USA; 2Veterans Affairs Medical Center, Birmingham, Alabama, USA

Abstract: Insulin regulates a large number of genes in a tissue-specific manner. We have previously identified genes modulated by insulin in the liver and in liver-derived cells that have not yet been characterized as insulin regulated, and results of these previous studies indicated that numerous genes are induced by insulin via the MEK-ERK pathway. We now describe new studies indicating that Gadd45-β can be induced by acute insulin treatment. Although other regulators of Gadd45-β expression may utilize the MEK-ERK pathway, the data indicate that insulin utilizes signaling pathways separate from either MEK-ERK, PI3-K, or p38 signaling pathways in the regulation of Gadd45-β transcription. Our findings show that activation of a downstream effector of multiple signaling pathways, mTOR, was required for insulin-induction of Gadd45-β gene transcription. Increased expression of Gadd45-β can inhibit c-Jun N-terminal kinase (JNK) activity. Since TNFα is increased during inflammation, and acts, at least in part, via the JNK signaling pathway, insulin induction of Gadd45-β suggests a mechanism for the anti-inflammatory actions of insulin.
Keywords: insulin, Gadd45−β, mTOR, ERK, PI3-kinase, p38, JNK

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]